ID   OST48_HUMAN             Reviewed;         456 AA.
AC   P39656; B2RDQ4; B4DJE3; B4DLI2; O43244; Q5VWA5; Q8NI93; Q9BUI2;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   16-JUN-2009, sequence version 4.
DT   10-MAY-2017, entry version 170.
DE   RecName: Full=Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit;
DE            Short=DDOST 48 kDa subunit;
DE            Short=Oligosaccharyl transferase 48 kDa subunit;
DE   Flags: Precursor;
GN   Name=DDOST; Synonyms=KIAA0115, OST48; ORFNames=OK/SW-cl.45;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT GLY-8.
RX   PubMed=9367678; DOI=10.1006/geno.1997.4966;
RA   Yamagata T., Tsuru T., Momoi M.Y., Suwa K., Nozaki Y., Mukasa T.,
RA   Ohashi H., Fukushima Y., Momoi T.;
RT   "Genome organization of human 48-kDa oligosaccharyltransferase
RT   (DDOST).";
RL   Genomics 45:535-540(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT GLY-8.
RC   TISSUE=Bone marrow;
RX   PubMed=7788527; DOI=10.1093/dnares/2.1.37;
RA   Nagase T., Miyajima N., Tanaka A., Sazuka T., Seki N., Sato S.,
RA   Tabata S., Ishikawa K., Kawarabayasi Y., Kotani H., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. III.
RT   The coding sequences of 40 new genes (KIAA0081-KIAA0120) deduced by
RT   analysis of cDNA clones from human cell line KG-1.";
RL   DNA Res. 2:37-43(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3), AND
RP   VARIANT GLY-8.
RC   TISSUE=Subthalamic nucleus, Synovium, and Umbilical cord blood;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT GLY-8.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT GLY-8.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 9-456 (ISOFORM 1).
RC   TISSUE=Colon adenocarcinoma;
RA   Shichijo S., Itoh K.;
RT   "Identification of immuno-peptidmics that are recognized by tumor-
RT   reactive CTL generated from TIL of colon cancer patients.";
RL   Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   FUNCTION.
RX   PubMed=22467853; DOI=10.1242/jcs.103952;
RA   Roboti P., High S.;
RT   "The oligosaccharyltransferase subunits OST48, DAD1 and KCP2 function
RT   as ubiquitous and selective modulators of mammalian N-glycosylation.";
RL   J. Cell Sci. 125:3474-3484(2012).
RN   [10]
RP   IDENTIFICATION IN THE OLIGOSACCHARYLTRANSFERASE COMPLEX.
RX   PubMed=25135935; DOI=10.1083/jcb.201404083;
RA   Cherepanova N.A., Shrimal S., Gilmore R.;
RT   "Oxidoreductase activity is necessary for N-glycosylation of cysteine-
RT   proximal acceptor sites in glycoproteins.";
RL   J. Cell Biol. 206:525-539(2014).
RN   [11]
RP   IDENTIFICATION IN THE OLIGOSACCHARYLTRANSFERASE COMPLEX.
RX   PubMed=23606741; DOI=10.1242/jcs.115410;
RA   Dumax-Vorzet A., Roboti P., High S.;
RT   "OST4 is a subunit of the mammalian oligosaccharyltransferase required
RT   for efficient N-glycosylation.";
RL   J. Cell Sci. 126:2595-2606(2013).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [14]
RP   VARIANT CDG1R ASP-217.
RX   PubMed=22305527; DOI=10.1016/j.ajhg.2011.12.024;
RA   Jones M.A., Ng B.G., Bhide S., Chin E., Rhodenizer D., He P.,
RA   Losfeld M.E., He M., Raymond K., Berry G., Freeze H.H., Hegde M.R.;
RT   "DDOST mutations identified by whole-exome sequencing are implicated
RT   in congenital disorders of glycosylation.";
RL   Am. J. Hum. Genet. 90:363-368(2012).
CC   -!- FUNCTION: Essential subunit of the N-oligosaccharyl transferase
CC       (OST) complex which catalyzes the transfer of a high mannose
CC       oligosaccharide from a lipid-linked oligosaccharide donor to an
CC       asparagine residue within an Asn-X-Ser/Thr consensus motif in
CC       nascent polypeptide chains. Required for the assembly of both
CC       SST3A- and SS3B-containing OST complexes. Required for efficient
CC       N-glycosylation. {ECO:0000250|UniProtKB:Q05052,
CC       ECO:0000269|PubMed:22467853, ECO:0000305}.
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBUNIT: Component of the oligosaccharyltransferase (OST) complex.
CC       OST exists in two different complex forms which contain common
CC       core subunits RPN1, RPN2, OST48, OST4, DAD1 and TMEM258, either
CC       STT3A or STT3B as catalytic subunits, and form-specific accessory
CC       subunits. OST can form stable complexes with the Sec61 complex or
CC       with both the Sec61 and TRAP complexes (By similarity).
CC       {ECO:0000250|UniProtKB:Q05052, ECO:0000269|PubMed:23606741,
CC       ECO:0000269|PubMed:25135935, ECO:0000305}.
CC   -!- INTERACTION:
CC       Q86WV6:TMEM173; NbExp=2; IntAct=EBI-358866, EBI-2800345;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q29381}; Single-pass type I membrane
CC       protein {ECO:0000250|UniProtKB:Q29381}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P39656-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P39656-2; Sequence=VSP_055498;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P39656-3; Sequence=VSP_055499;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Congenital disorder of glycosylation 1R (CDG1R)
CC       [MIM:614507]: A form of congenital disorder of glycosylation, a
CC       multisystem disorder caused by a defect in glycoprotein
CC       biosynthesis and characterized by under-glycosylated serum
CC       glycoproteins. Congenital disorders of glycosylation result in a
CC       wide variety of clinical features, such as defects in the nervous
CC       system development, psychomotor retardation, dysmorphic features,
CC       hypotonia, coagulation disorders, and immunodeficiency. The broad
CC       spectrum of features reflects the critical role of N-glycoproteins
CC       during embryonic development, differentiation, and maintenance of
CC       cell functions. {ECO:0000269|PubMed:22305527}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the DDOST 48 kDa subunit family.
CC       {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-18 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB93478.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D89060; BAA23670.1; -; Genomic_DNA.
DR   EMBL; D29643; BAA06126.1; -; mRNA.
DR   EMBL; AK296041; BAG58805.1; -; mRNA.
DR   EMBL; AK297009; BAG59544.1; -; mRNA.
DR   EMBL; AK315633; BAG38001.1; -; mRNA.
DR   EMBL; AL391357; CAH73476.1; -; Genomic_DNA.
DR   EMBL; CH471134; EAW94938.1; -; Genomic_DNA.
DR   EMBL; BC002594; AAH02594.1; -; mRNA.
DR   EMBL; AB062391; BAB93478.1; ALT_INIT; mRNA.
DR   CCDS; CCDS212.1; -. [P39656-1]
DR   PIR; S66254; A44654.
DR   RefSeq; NP_005207.2; NM_005216.4.
DR   UniGene; Hs.523145; -.
DR   ProteinModelPortal; P39656; -.
DR   BioGrid; 108017; 87.
DR   IntAct; P39656; 41.
DR   MINT; MINT-1144346; -.
DR   STRING; 9606.ENSP00000364188; -.
DR   BindingDB; P39656; -.
DR   ChEMBL; CHEMBL4239; -.
DR   iPTMnet; P39656; -.
DR   PhosphoSitePlus; P39656; -.
DR   SwissPalm; P39656; -.
DR   BioMuta; DDOST; -.
DR   DMDM; 239938926; -.
DR   EPD; P39656; -.
DR   MaxQB; P39656; -.
DR   PaxDb; P39656; -.
DR   PeptideAtlas; P39656; -.
DR   PRIDE; P39656; -.
DR   TopDownProteomics; P39656-1; -. [P39656-1]
DR   DNASU; 1650; -.
DR   Ensembl; ENST00000375048; ENSP00000364188; ENSG00000244038. [P39656-1]
DR   Ensembl; ENST00000415136; ENSP00000399457; ENSG00000244038. [P39656-1]
DR   GeneID; 1650; -.
DR   KEGG; hsa:1650; -.
DR   UCSC; uc001bdo.1; human. [P39656-1]
DR   CTD; 1650; -.
DR   DisGeNET; 1650; -.
DR   GeneCards; DDOST; -.
DR   GeneReviews; DDOST; -.
DR   HGNC; HGNC:2728; DDOST.
DR   HPA; CAB009746; -.
DR   HPA; HPA046841; -.
DR   HPA; HPA052867; -.
DR   MalaCards; DDOST; -.
DR   MIM; 602202; gene.
DR   MIM; 614507; phenotype.
DR   neXtProt; NX_P39656; -.
DR   OpenTargets; ENSG00000244038; -.
DR   Orphanet; 300536; DDOST-CDG.
DR   PharmGKB; PA27195; -.
DR   eggNOG; KOG2754; Eukaryota.
DR   eggNOG; ENOG410XSF3; LUCA.
DR   GeneTree; ENSGT00390000017294; -.
DR   HOGENOM; HOG000173744; -.
DR   HOVERGEN; HBG053378; -.
DR   InParanoid; P39656; -.
DR   KO; K12670; -.
DR   OMA; AFSMMIG; -.
DR   OrthoDB; EOG091G07Z5; -.
DR   PhylomeDB; P39656; -.
DR   TreeFam; TF314821; -.
DR   Reactome; R-HSA-1799339; SRP-dependent cotranslational protein targeting to membrane.
DR   Reactome; R-HSA-446203; Asparagine N-linked glycosylation.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-879415; Advanced glycosylation endproduct receptor signaling.
DR   UniPathway; UPA00378; -.
DR   ChiTaRS; DDOST; human.
DR   GeneWiki; DDOST; -.
DR   GenomeRNAi; 1650; -.
DR   PRO; PR:P39656; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000244038; -.
DR   CleanEx; HS_DDOST; -.
DR   ExpressionAtlas; P39656; baseline and differential.
DR   Genevisible; P39656; HS.
DR   GO; GO:0035577; C:azurophil granule membrane; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0008250; C:oligosaccharyltransferase complex; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0043234; C:protein complex; IDA:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0006486; P:protein glycosylation; ISS:UniProtKB.
DR   GO; GO:0006487; P:protein N-linked glycosylation; IDA:UniProtKB.
DR   GO; GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome.
DR   GO; GO:0034097; P:response to cytokine; IDA:UniProtKB.
DR   GO; GO:0042110; P:T cell activation; IDA:UniProtKB.
DR   Gene3D; 3.40.50.880; -; 1.
DR   InterPro; IPR029062; Class_I_gatase-like.
DR   InterPro; IPR005013; DDOST_48_kDa_subunit.
DR   PANTHER; PTHR10830; PTHR10830; 1.
DR   Pfam; PF03345; DDOST_48kD; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome;
KW   Congenital disorder of glycosylation; Disease mutation;
KW   Endoplasmic reticulum; Membrane; Polymorphism; Reference proteome;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     42       {ECO:0000250}.
FT   CHAIN        43    456       Dolichyl-diphosphooligosaccharide--
FT                                protein glycosyltransferase 48 kDa
FT                                subunit.
FT                                /FTId=PRO_0000021957.
FT   TOPO_DOM     43    427       Lumenal. {ECO:0000255}.
FT   TRANSMEM    428    447       Helical. {ECO:0000255}.
FT   TOPO_DOM    448    456       Cytoplasmic. {ECO:0000255}.
FT   VAR_SEQ      69    105       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055498.
FT   VAR_SEQ     124    141       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055499.
FT   VARIANT       8      8       R -> G (in dbSNP:rs537816).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:7788527,
FT                                ECO:0000269|PubMed:9367678,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_047911.
FT   VARIANT     217    217       G -> D (in CDG1R; dbSNP:rs387906831).
FT                                {ECO:0000269|PubMed:22305527}.
FT                                /FTId=VAR_067544.
FT   CONFLICT    229    229       P -> R (in Ref. 3; BAG59544).
FT                                {ECO:0000305}.
FT   CONFLICT    343    343       G -> A (in Ref. 1; BAA23670).
FT                                {ECO:0000305}.
FT   CONFLICT    434    434       S -> P (in Ref. 1; BAA23670 and 2;
FT                                BAA06126). {ECO:0000305}.
SQ   SEQUENCE   456 AA;  50801 MW;  2707ABAC8FF158CB CRC64;
     MGYFRCARAG SFGRRRKMEP STAARAWALF WLLLPLLGAV CASGPRTLVL LDNLNVRETH
     SLFFRSLKDR GFELTFKTAD DPSLSLIKYG EFLYDNLIIF SPSVEDFGGN INVETISAFI
     DGGGSVLVAA SSDIGDPLRE LGSECGIEFD EEKTAVIDHH NYDISDLGQH TLIVADTENL
     LKAPTIVGKS SLNPILFRGV GMVADPDNPL VLDILTGSST SYSFFPDKPI TQYPHAVGKN
     TLLIAGLQAR NNARVIFSGS LDFFSDSFFN SAVQKAAPGS QRYSQTGNYE LAVALSRWVF
     KEEGVLRVGP VSHHRVGETA PPNAYTVTDL VEYSIVIQQL SNGKWVPFDG DDIQLEFVRI
     DPFVRTFLKK KGGKYSVQFK LPDVYGVFQF KVDYNRLGYT HLYSSTQVSV RPLQHTQYER
     FIPSAYPYYA SAFSMMLGLF IFSIVFLHMK EKEKSD
//
